MTOR and atrial fibrillation: Four additional miRNAs dysregulated in AF patients (miR-430-3p, miR-146b-5p, miR-630 and miR-367) may influence mTOR and Hippo signaling pathways and have been indicated as prospective feasible biomarkers for the diagnosis of AF progression [97].